Skip to main content
PMC home page
Public Health Reports logoLink to Public Health Reports
. 1991 May-Jun;106(3):326–333.

Quantifying the disease impact of cigarette smoking with SAMMEC II software.

J M Shultz 1, T E Novotny 1, D P Rice 1
PMCID: PMC1580242  PMID: 1905056

Abstract

Smoking-Attributable Mortality, Morbidity, and Economic Costs Software, Release II (SAMMEC II) has been developed for the Office on Smoking and Health, Public Health Service, to permit rapid calculation of deaths, years of potential life lost, direct health-care costs, indirect mortality costs, and disability costs associated with cigarette smoking. For the mortality-related measures, age-specific and age-adjusted rates are also calculated. The pivotal epidemiologic measure in these calculations is the smoking-attributable fraction, and attributal risk measure. A multiple-measure approach (attributable mortality and economic costs) to quantifying a health problem is termed "disease impact estimation." Previously, national and State-specific estimates of smoking-attributable mortality and economic costs were calculated using SAMMEC software, the predecessor of SAMMEC II. SAMMEC II is completely menu-driven and operates within the Lotus 1-2-3 software as a set of linked spreadsheets. SAMMEC II adapts national epidemiologic methods for use by State and local health departments. Increased exposure of public health professionals to disease impact estimation techniques, as demonstrated by SAMMEC II, will lead to improvements in both methodology and the quality of smoking-related health data. The primary purpose of SAMMEC II, however, is to provide State or locality-specific data on the health consequences of smoking to policymakers and public health professionals in these jurisdictions.

Full text

PDF
326

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Breukelman F. N., Zeitz P. S., Novotny T. E. Smoking in Delaware: economic costs and deaths attributable to cigarette smoking in the state, 1985. Del Med J. 1988 Dec;60(12):735-6, 739. [PubMed] [Google Scholar]
  2. Hodgson T. A., Kopstein A. N. Health care expenditures for major diseases in 1980. Health Care Financ Rev. 1984 Summer;5(4):1–12. [PMC free article] [PubMed] [Google Scholar]
  3. Hodgson T. A. The state of the art of cost-of-illness estimates. Adv Health Econ Health Serv Res. 1983;4:129–164. [PubMed] [Google Scholar]
  4. Parker D. L., Shultz J. M., Gertz L., Berkelman R., Remington P. L. The social and economic costs of alcohol abuse in Minnesota, 1983. Am J Public Health. 1987 Aug;77(8):982–986. doi: 10.2105/ajph.77.8.982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Rice D. P., Hodgson T. A., Sinsheimer P., Browner W., Kopstein A. N. The economic costs of the health effects of smoking, 1984. Milbank Q. 1986;64(4):489–547. [PubMed] [Google Scholar]
  6. Shultz J. M., Moen M. E., Pechacek T. F., Harty K. C., Skubic M. A., Gust S. W., Dean A. G. The Minnesota Plan for Nonsmoking and Health: the legislative experience. J Public Health Policy. 1986 Autumn;7(3):300–313. [PubMed] [Google Scholar]
  7. Smith P. F., Shultz J. M., Morse D. L. Assessing the damage from cigarette smoking in New York State. N Y State J Med. 1990 Feb;90(2):56–60. [PubMed] [Google Scholar]
  8. Walter S. D. The estimation and interpretation of attributable risk in health research. Biometrics. 1976 Dec;32(4):829–849. [PubMed] [Google Scholar]
  9. Warner K. E. Health and economic implications of a tobacco-free society. JAMA. 1987 Oct 16;258(15):2080–2086. [PubMed] [Google Scholar]

Articles from Public Health Reports are provided here courtesy of SAGE Publications

RESOURCES